undamentalytics Newsletter

Armistice Capital Master Fund Ltd.: insider trades

Director, 10% owner at 6 companies we cover. 24 open-market purchases and 3 sales not made under a pre-set plan, reported from August 24, 2017 to June 28, 2023.

Would copying Armistice Capital Master Fund Ltd.’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 3 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on March 28, 2019 into $1,269 by November 2, 2026, −23.8% a year. The copy held shares only 29% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $17,249, +7.5% a year (the S&P 500 held throughout made $30,067, +15.6% a year). Beta against the index was 0.64. Twelve months after each report, the average purchase was −72.0% against the S&P 500 (median −61.2%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −68.7%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k$30.0k 20192020202120222023202420252026 $30.1k$17.2k$1.3k
Copying Armistice Capital Master Fund Ltd.S&P 500, same days investedS&P 500, held throughout $10,000 copying Armistice Capital Master Fund Ltd.’s open-market purchases from March 28, 2019, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−23.8%
S&P 500, same days invested
+7.5% (held throughout +15.6%)
Time in shares
29%
Sharpe ratio (S&P 500)
−0.46 (0.70)
Biggest drop (S&P 500)
−91% (−34%)
Market sensitivity (beta)
0.64
Purchases copied
3

Trade by trade

Armistice Capital Master Fund Ltd.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 3 −5.1% −18.1% 33% 2 — — Not enough years
Purchases, 6 months after the report 3 −42.6% −41.9% 0% 2 — — Not enough years
Purchases, 12 months after the report 3 −72.0% −61.2% 0% 2 — — Not enough years
Purchases, 12 months after the trade 2 −68.7% −68.7% 0% 2 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Avalo Therapeutics, Inc. AVTX —201August 24, 2017June 28, 2023
Kiora Pharmaceuticals Inc KPRX —20April 20, 2018May 30, 2018
Filana Therapeutics, Inc. FLNA —01October 5, 2018October 5, 2018
Achieve Life Sciences, Inc. ACHV —01June 13, 2019June 13, 2019
Tenax Therapeutics, Inc. TENX —10September 9, 2020September 9, 2020
Aytu Biopharma, Inc AYTU —10December 15, 2020December 15, 2020

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 28, 2023June 26, 2023 AVTX Sale $2,162,594 not yetnot yetnot yet
February 28, 2022February 24, 2022 AVTX Purchase $111,600 not yetnot yetnot yet
January 11, 2022January 7, 2022 AVTX Purchase $644,965 not yetnot yetnot yet
December 15, 2020December 11, 2020 AYTU Purchase $8,000,004 +41.0%−104.5%−102.4%
December 7, 2020December 3, 2020 AVTX Purchase $48,800 not yetnot yetnot yet
September 9, 2020September 4, 2020 TENX Purchase $45,547 not yetnot yetnot yet
June 11, 2020June 9, 2020 AVTX Purchase $5,127,391 not yetnot yetnot yet
March 19, 2020March 17, 2020 AVTX Purchase $4,058,380 not yetnot yetnot yet
September 6, 2019September 4, 2019 AVTX Purchase $6,706,000 not yetnot yetnot yet
June 13, 2019June 11, 2019 ACHV Sale $134,821 not yetnot yetnot yet
June 11, 2019June 7, 2019 AVTX Purchase $48,750 −38.1%−61.2%not yet
May 28, 2019May 23, 2019 AVTX Purchase $145,539 not yetnot yetnot yet
March 27, 2019March 25, 2019 AVTX Purchase $273,299 −18.1%−50.4%−35.0%
December 18, 2018December 14, 2018 AVTX Purchase $165,314 not yetnot yetnot yet
November 26, 2018November 21, 2018 AVTX Purchase $179,300 not yetnot yetnot yet
November 20, 2018November 16, 2018 AVTX Purchase $177,283 not yetnot yetnot yet
November 15, 2018November 13, 2018 AVTX Purchase $120,552 not yetnot yetnot yet
October 5, 2018October 3, 2018 FLNA Sale $671,585 not yetnot yetnot yet
September 27, 2018September 25, 2018 AVTX Purchase $94,675 not yetnot yetnot yet
August 1, 2018July 30, 2018 AVTX Purchase $12,130 not yetnot yetnot yet
May 30, 2018May 25, 2018 KPRX Purchase $33,392 not yetnot yetnot yet
May 17, 2018May 15, 2018 AVTX Purchase $467,468 not yetnot yetnot yet
April 20, 2018April 18, 2018 KPRX Purchase $1,233,552 not yetnot yetnot yet
April 18, 2018April 16, 2018 AVTX Purchase $512,181 not yetnot yetnot yet
November 24, 2017November 22, 2017 AVTX Purchase $54,292 not yetnot yetnot yet
September 1, 2017August 30, 2017 AVTX Purchase $29,879 not yetnot yetnot yet
August 24, 2017August 22, 2017 AVTX Purchase $79,456 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Armistice Capital Master Fund Ltd. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.